1. South Korea Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
AbClon, Inc.

AbClon, Inc.

KKRX:174900
21,550.00
KRW
-1,400.00
(-6.10%)
-896.64EPS
553.93BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
231.59
249.26
196.15
256.01
279.97
286.14
1,001.8
192.2
197.51
225.38
189.51
139.95
256.94
273.15
Basic EPS, GAAP
-92
-449.5
-991
-131
-117.5
-61.5
178.87
-447
-670
-612
-850
-975
-976
-896.64
Free Cash Flow per Basic Share
-182.89
-218.96
-566.36
-36.68
-95.92
91.15
-767.09
-630.39
-599.84
-501.96
-627.98
-870.95
-787.39
-712.82
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-44.28
-183.04
981.42
883.47
1,278.84
1,305.79
2,451.31
1,919.69
1,267.1
2,359.48
1,711.73
1,662.19
3,014.94
2,648.57
Tangible Book Value per Share
-47.72
-185.43
979.73
868.54
1,260.76
1,279.78
2,423.47
1,890.96
1,239.09
2,331.47
1,677.33
1,633.17
2,990.36
2,624.48
Basic Weighted Avg Shares
7
7
10
12
13
14
14
14
15
15
15
17
18
19
Sales/Revenue/Turnover
1,627
1,786
1,948
3,120
3,532
3,921
14,375
2,771
3,018
3,404
2,877
2,340
4,714
5,308
Operating Margin (%)
-89
-115.69
-158.48
-51.47
-43.74
-49.88
29.8
-237.13
-338.93
-256.74
-404.75
-666.24
-374.11
-336.44
Depreciation Expense
145
183
260
306
295
353
501
1,129
1,395
1,517
1,684
1,591
1,127
859
Net Income, GAAP
-646
-3,222
-9,842
-1,597
-1,483
-843
2,567
-6,445
-10,238
-9,244
-12,904
-16,302
-17,907
-17,423
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
45.44
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-39.73
-180.34
-505.24
-51.17
-41.97
-21.49
17.85
-232.57
-339.22
-271.54
-448.53
-696.7
-379.86
-328.26
Working Capital
4,262
-664
12,308
11,137
14,758
13,049
25,542
16,910
1,845
16,376
1,721
5,117
36,682
29,435
LT Debt
- -
- -
2,000
2,000
- -
- -
5,014
5,093
71
4,610
25
9
46
298
Total Equity
-600
-2,482
13,307
11,979
17,392
18,699
35,378
29,329
19,359
36,737
27,227
29,406
60,439
53,070
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
7.41
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
8.34
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
-12.63
-10.1
-4.67
9.53
-19.98
-42.05
-33.31
-41.14
-58.69
-40.22
-41.07

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
7,039
7,118
7,141
LT Borrowings
- -
- -
- -
LT Finance Leases
46
307
298
Preferred Equity and Hybrid Capital
365
296
296
Shares Outstanding
20
20
20
Market Capitalization
846,834
1,129,776
553,929

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
46,035
43,514
39,606
Cash, Cash Equivalents & STI
45,011
42,111
36,376
Accounts Receivable, Net
280
139
1,208
Inventories
187
164
192
Total Current Liabilities
9,353
8,906
10,171
Payables & Accruals
- -
- -
- -
ST Debt
7,039
7,118
7,141
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.82%
28.68%
105.53%
Free Cash Flow
-106.2%
12.25%
-0.79%
Net Income, GAAP
-76.48%
24.98%
9.85%
Sales/Revenue/Turnover
35.93%
17.8%
101.47%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
437
395
798
710
2,340
2025
413
1,112
1,566
1,623
4,714
2026
434
1,684
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-358
-236
-198
-187.09
-975
2025
-340
-189
-184.46
-264.89
-976
2026
-139.63
-309
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Jong-Seo Lee
Full Time Employees
66
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
1401 285, Digital-ro Seoul SL South Korea 08381
IPO Date
Sep 18, 2017
Website
abclon.com
Similar Companies
PayPal Holdings, Inc. (NASDAQ:PYPL)
Shopify Inc. (NASDAQ:SHOP)
Greenland Mines Ltd (NASDAQ:GRML)
Block, Inc. (NYSE:XYZ)
Netcapital Inc. (NASDAQ:NCPL)
Shopify, Inc. Class A (TSX:SHOP)
Business
AbClon Inc. (174900.KQ) develops, manufactures and distributes antibody drugs targeting cancers and autoimmune diseases, leveraging proprietary platforms including NEST for novel epitope screening, AffiMab for bispecific antibodies and CAR-T technologies such as zCAR-T and Nespe-cel; its pipeline features AC101 (HLX22, licensed to Henlius for HER2-positive gastric and breast cancers), AT101 (Nespe-cel for relapsed/refractory blood cancers), AT501 for solid tumors including ovarian cancer, AM105 for colorectal cancer, AM109 for prostate cancer, and additional candidates like AC103, AC104, AC106, AC203, AM201, AM101, AM102 and AM103 for breast, gastric, colon, hematologic and autoimmune indications. The company operates primarily in South Korea with research activities in Sweden, serving domestic and international markets including technology transfers to partners in Turkey. Founded in 2010 and headquartered in Seoul, South Korea, AbClon focuses on bio-synergy antibodies and advanced cell therapies for intractable diseases. Recent developments include a 36 billion KRW equity financing via perpetual convertible bonds and preferred stocks from biotech investors such as DSC Investment, Paratus Investment and Chong Kun Dang in 2025 to support clinical trials and R&D; fast-track advanced biopharmaceutical and orphan drug designations from South Korea's MFDS for Nespe-cel (AT101), targeting 2026 approval with Phase 2 data showing 94% objective response rate; U.S. patent grant for HER2 Affibody-based switchable CAR-T technology; progression of licensed AC101 (HLX22) into global Phase 3 trials with U.S. and European orphan drug designations; and expanded partnerships including Chong Kun Dang's exclusive domestic sales rights for Nespe-cel and joint development in bispecific antibodies.